Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

about

A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images.

P2860

Q55617317-F5F4A097-C7FC-4DEE-853D-02D69A11672A

P2860

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

Item

http://www.wikidata.org/entity/Q57276328

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2017

@uk

name

Using biomarkers to predict TB ...... ment shortening clinical trial

@en

Using biomarkers to predict TB ...... ment shortening clinical trial

@nl

type

Item

label

Using biomarkers to predict TB ...... ment shortening clinical trial

@en

Using biomarkers to predict TB ...... ment shortening clinical trial

@nl

prefLabel

Using biomarkers to predict TB ...... ment shortening clinical trial

@en

Using biomarkers to predict TB ...... ment shortening clinical trial

@nl

P1476

Using biomarkers to predict TB ...... ment shortening clinical trial

@en

P2093

Alex Rosenthal

http://www.w3.org/2001/XMLSchema#string

Andreas H Diacon

http://www.w3.org/2001/XMLSchema#string

André G Loxton

http://www.w3.org/2001/XMLSchema#string

Bronwyn Smith

http://www.w3.org/2001/XMLSchema#string

Christopher Whalen

http://www.w3.org/2001/XMLSchema#string

Clifton E Barry Iii

http://www.w3.org/2001/XMLSchema#string

David Alland

http://www.w3.org/2001/XMLSchema#string

Gerhard Walzl

http://www.w3.org/2001/XMLSchema#string

Guolong Zhang

http://www.w3.org/2001/XMLSchema#string

Hong Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial

Rapid molecular detection of tuberculosis and rifampin resistance

Understanding pharmacokinetics to improve tuberculosis treatment outcome.

Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression

Evaluation of time to detection of Mycobacterium tuberculosis in broth culture as a determinant for end points in treatment trials.

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/GATESOPENRES.12750.1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29528048

http://www.w3.org/2001/XMLSchema#string

P921

cycle threshold

pulmonary tuberculosis

P932

5841574

http://www.w3.org/2001/XMLSchema#string

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

about

P2860

P2860

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932